Trial | NCT00553293  Report issue

Title

Nordic Luveris Study
Recombinant LH Supplementation to Recombinant FSH During the Final Days of Controlled Ovarian Stimulation for IVF: a Multicentre, Prospective, Randomized, Controlled Trial

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    follitropin alfa lutropin alpha ...

  • Study Participants

    526
To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
Study Started
Aug 31
2003
Study Completion
Nov 30
2004
Last Update
Nov 04
2007
Estimate

Drug recombinant luteinizing hormone (Luveris)

75 iu/day form cycle day 6

  • Other names: Luveris

Drug recombinant follicle stimulating hormone (Gonal-f)

rFSH 150 iu/day

  • Other names: Gonal-f

A,1 Active Comparator

rFSH + rLH arm

A,2 Placebo Comparator

rFSH alone

Criteria 

Inclusion Criteria:

Age below 40
Infertility treatable by IVF or ICSI
Regular cycles

Exclusion Criteria:

NA
No Results Posted